Data Characteristics
Drug R&D data primarily includes clinical trial reports, drug inserts, pharmacological research papers, drug interaction databases, adverse event reports, and various guidelines. These documents typically exist as PDFs, Word files, or structured databases. Update frequency is relatively low, usually occurring with drug market approvals, guideline revisions, or new clinical study publications. Document structures are complex, containing numerous specialized terms, dosage units (e.g., mg, g, ml), administration routes, drug interaction levels, disease codes (e.g., ICD-10), and laboratory indicators. Fields often combine unstructured text descriptions with semi-structured tabular data.
Constraints on Vector Models and Indexing
The complexity of drug R&D documents imposes specific requirements on vector models and indexing. First, specialized terminology and high contextual dependency in documents demand strong semantic understanding from vector models. Models must distinguish between similar but semantically distinct drug names or disease descriptions. Second, numerical information like dosages and frequencies are closely tied to units. Simple text segmentation can break this integrity, affecting recall accuracy. Tabular data in drug inserts and clinical trial reports, with their row and column logical relationships, require special handling during vectorization to avoid information loss. The low update frequency means model training and index building can be relatively stable, but incremental update efficiency and consistency are important. Multi-source heterogeneous data requires the index to integrate different data formats while maintaining retrieval performance.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 800–1200 characters | Balances contextual completeness with vector model processing capability, especially for lengthy clinical reports. |
Chunk Overlap Length (Overlap Length) | 100–200 characters | Ensures semantic continuity across segments, preventing critical information from being split. |
Recall count (Recall Count) | 8–15 entries | Increases retrieval coverage, providing sufficient candidates for subsequent re-ranking and generation. |
Similarity threshold (Similarity Threshold) | Calibrate based on actual measurements | Requires tuning using metrics like F1-score, depending on the specific dataset and model performance. |
Rerank result count (Re-ranking Return Count) | Top 3–5 entries | Filters for the most relevant few results, improving the precision of the final output. |
Vector Model Normalization | Enabled | Adapts to vector models that do not include built-in normalization, such as Doubao embedding. |
Common Pitfalls
- Symptom: After uploading documents, the knowledge base remains in "processing" status for an extended period or directly reports
PARSE_FILE_TIMEOUT. Reason: Drug R&D documents often contain many images, complex tables, or extremely long texts. The default file parsing timeout is insufficient to complete processing. - Symptom: After switching vector models, the knowledge base does not function correctly, reporting
404 page not foundorInvalid API Key. Reason: The API address or key for the newly configured vector model channel is incorrect, or the model service is not yet fully ready. - Symptom: Retrieval results show incomplete or incorrect drug dosage or interaction level information. Reason: Improper document segmentation strategy splits critical numerical values from units or modifiers, leading to semantic loss during vectorization.
Verification Steps
- Upload representative drug inserts and clinical trial reports. Check if the knowledge base status displays "Completed".
- Use queries highly relevant to key terms in R&D documents. Verify that recall results include correct and relevant original text snippets, and confirm that key numerical values and units are complete.
- For query results, evaluate the distribution of similarity scores. Confirm consistency with human judgment of relevance trends.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.